CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: mirex
Accession: CHEBI:34852
browse the term
Definition: A chlorocarbon that has formula C10Cl12.
Synonyms: exact_synonym: 1,1a,2,2,3,3a,4,5,5,5a,5b,6-dodecachlorooctahydro-1H-1,3,4-(methanetriyl)cyclobuta[cd]pentalene
related_synonym: 1,2,3,4,5,5,6,7,8,9,10,10-dodecachloropentacyclo[5.3.0.0(2,6).0(3,9).0(4,8)]decane; CG-1283; Dechlorane; Formula=C10Cl12; InChI=1S/C10Cl12/c11-1-2(12)7(17)4(14)3(13,5(1,15)9(7,19)20)6(1,16)10(21,22)8(2,4)18; InChIKey=GVYLCNUFSHDAAW-UHFFFAOYSA-N; SMILES=ClC1(Cl)C2(Cl)C3(Cl)C4(Cl)C(Cl)(Cl)C5(Cl)C3(Cl)C1(Cl)C5(Cl)C24Cl; dodecachlorooctahydro-1,3,4-metheno-2H-cyclobuta[cd]pentalene; perchlorodihomocubane; perchloropentacyclo[5.2.1.0(2,6).0(3,9).0(5,8)]decane; perchloropentacyclodecane
xref: CAS:2385-85-5; Gmelin:1789502; HMDB:HMDB0059573; KEGG:C14184
xref_mesh: MESH:D008917
xref: PPDB:1294; Patent:US2702305; Patent:US2724730; Reaxys:2010845; Wikipedia:Mirex
G
Abcc6
ATP binding cassette subfamily C member 6
decreases expression
EXP
Mirex results in decreased expression of ABCC6 mRNA
CTD
PMID:23153324
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
G
Abcg5
ATP binding cassette subfamily G member 5
increases expression
EXP
Mirex results in increased expression of ABCG5 mRNA
CTD
PMID:23153324
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Aqp9
aquaporin 9
decreases expression
EXP
Mirex results in decreased expression of AQP9 mRNA
CTD
PMID:23153324
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Ar
androgen receptor
multiple interactions
ISO
[DDT analog co-treated with Hexachlorocyclohexane analog co-treated with Chlorobenzenes co-treated with Mirex co-treated with Polychlorinated Biphenyls co-treated with Chlordan co-treated with Toxaphene co-treated with Hydrocarbons, Chlorinated] inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]
CTD
PMID:21295777
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Atp1b1
ATPase Na+/K+ transporting subunit beta 1
decreases expression
EXP
Mirex results in decreased expression of ATP1B1 mRNA
CTD
PMID:23153324
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
G
Atp2c1
ATPase secretory pathway Ca2+ transporting 1
decreases expression
EXP
Mirex results in decreased expression of ATP2C1 mRNA
CTD
PMID:23153324
NCBI chr 8:106,034,777...106,155,854
Ensembl chr 8:106,034,636...106,156,006
G
Bcat1
branched chain amino acid transaminase 1
increases expression
EXP
Mirex results in increased expression of BCAT1 mRNA
CTD
PMID:23153324
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
G
Ccnb1
cyclin B1
increases expression
EXP
Mirex results in increased expression of CCNB1 mRNA
CTD
PMID:23153324
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb2
cyclin B2
increases expression
EXP
Mirex results in increased expression of CCNB2 mRNA
CTD
PMID:23153324
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Cdkn3
cyclin-dependent kinase inhibitor 3
increases expression
EXP
Mirex results in increased expression of CDKN3 mRNA
CTD
PMID:23153324
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
G
Cenpe
centromere protein E
increases expression
EXP
Mirex results in increased expression of CENPE mRNA
CTD
PMID:23153324
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
G
Chrna1
cholinergic receptor nicotinic alpha 1 subunit
decreases expression
EXP
Mirex results in decreased expression of CHRNA1 mRNA
CTD
PMID:23153324
NCBI chr 3:58,454,763...58,469,832
Ensembl chr 3:58,454,744...58,469,840
G
Csf3
colony stimulating factor 3
increases expression
EXP
Mirex results in increased expression of CSF3 mRNA
CTD
PMID:23153324
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression
EXP
Mirex results in increased expression of CYP2B1 mRNA; Mirex results in increased expression of CYP2B1 protein
CTD
PMID:1715015
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases expression
EXP
Mirex results in increased expression of CYP2B2 mRNA; Mirex results in increased expression of CYP2B2 protein
CTD
PMID:1715015
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions
ISO
Mirex results in increased expression of and results in increased activity of CYP2B10 protein
CTD
PMID:8722114
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
EXP
Mirex results in decreased expression of CYP2E1 protein
CTD
PMID:3113478
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Ect2
epithelial cell transforming 2
increases expression
EXP
Mirex results in increased expression of ECT2 mRNA
CTD
PMID:23153324
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
G
Elovl7
ELOVL fatty acid elongase 7
increases expression
EXP
Mirex results in increased expression of ELOVL7 mRNA
CTD
PMID:23153324
NCBI chr 2:39,789,229...39,858,579
Ensembl chr 2:39,789,250...39,856,845
G
Ereg
epiregulin
increases expression
EXP
Mirex results in increased expression of EREG mRNA
CTD
PMID:23153324
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
G
Esr1
estrogen receptor 1
multiple interactions
ISO
[DDT analog co-treated with Hexachlorocyclohexane analog co-treated with Chlorobenzenes co-treated with Mirex co-treated with Polychlorinated Biphenyls co-treated with Chlordan co-treated with Toxaphene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of ESR1 mRNA
CTD
PMID:21295777
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Hk2
hexokinase 2
increases expression
EXP
Mirex results in increased expression of HK2 mRNA
CTD
PMID:23153324
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
G
Kif18b
kinesin family member 18B
increases expression
EXP
Mirex results in increased expression of KIF18B mRNA
CTD
PMID:23153324
NCBI chr10:87,870,424...87,889,895
Ensembl chr10:87,870,428...87,889,850
G
Lmnb1
lamin B1
increases expression
EXP
Mirex results in increased expression of LMNB1 mRNA
CTD
PMID:23153324
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
G
Lrrc1
leucine rich repeat containing 1
increases expression
EXP
Mirex results in increased expression of LRRC1 mRNA
CTD
PMID:23153324
NCBI chr 8:78,239,897...78,407,347
Ensembl chr 8:78,239,900...78,406,490
G
Meox2
mesenchyme homeobox 2
increases expression
EXP
Mirex results in increased expression of MEOX2 mRNA
CTD
PMID:23153324
NCBI chr 6:53,856,760...53,917,467
Ensembl chr 6:53,856,758...53,917,467
G
Mmd
monocyte to macrophage differentiation-associated
increases expression
EXP
Mirex results in increased expression of MMD mRNA
CTD
PMID:23153324
NCBI chr10:75,073,278...75,101,528
Ensembl chr10:75,073,365...75,101,528
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
EXP
Mirex results in decreased expression of NNT mRNA
CTD
PMID:23153324
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
EXP
Mirex results in decreased expression of NR3C1 protein
CTD
PMID:1638671 PMID:1673321
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nt5dc2
5'-nucleotidase domain containing 2
increases expression
EXP
Mirex results in increased expression of NT5DC2 mRNA
CTD
PMID:23153324
NCBI chr16:6,322,485...6,330,538
Ensembl chr16:6,322,236...6,330,537
G
Odc1
ornithine decarboxylase 1
increases activity
EXP
Mirex results in increased activity of ODC1 protein
CTD
PMID:2283661
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
increases expression
EXP
Mirex results in increased expression of PTTG1 mRNA
CTD
PMID:23153324
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Rfc4
replication factor C subunit 4
increases expression
EXP
Mirex results in increased expression of RFC4 mRNA
CTD
PMID:23153324
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
G
Serpinb2
serpin family B member 2
increases expression
EXP
Mirex results in increased expression of SERPINB2 mRNA
CTD
PMID:23153324
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
G
Slc10a1
solute carrier family 10 member 1
decreases expression
EXP
Mirex results in decreased expression of SLC10A1 mRNA
CTD
PMID:23153324
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc16a1
solute carrier family 16 member 1
decreases expression
EXP
Mirex results in decreased expression of SLC16A1 mRNA
CTD
PMID:23153324
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
G
Slc16a4
solute carrier family 16, member 4
decreases expression
EXP
Mirex results in decreased expression of SLC16A4 mRNA
CTD
PMID:23153324
NCBI chr 2:194,911,075...194,933,162
Ensembl chr 2:194,911,236...194,933,117
G
Slc16a7
solute carrier family 16 member 7
decreases expression
EXP
Mirex results in decreased expression of SLC16A7 mRNA
CTD
PMID:23153324
NCBI chr 7:61,043,667...61,211,547
Ensembl chr 7:61,051,167...61,154,994
G
Slc17a3
solute carrier family 17 member 3
decreases expression
EXP
Mirex results in decreased expression of SLC17A3 mRNA
CTD
PMID:23153324
NCBI chr17:41,270,804...41,300,132
Ensembl chr17:41,270,812...41,295,256
G
Slc17a5
solute carrier family 17 member 5
decreases expression
EXP
Mirex results in decreased expression of SLC17A5 mRNA
CTD
PMID:23153324
NCBI chr 8:79,394,416...79,429,387
G
Slc19a2
solute carrier family 19 member 2
decreases expression
EXP
Mirex results in decreased expression of SLC19A2 mRNA
CTD
PMID:23153324
NCBI chr13:76,601,975...76,616,175
Ensembl chr13:76,601,900...76,616,172
G
Slc2a2
solute carrier family 2 member 2
decreases expression
EXP
Mirex results in decreased expression of SLC2A2 mRNA
CTD
PMID:23153324
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
G
Slc31a2
solute carrier family 31 member 2
decreases expression
EXP
Mirex results in decreased expression of SLC31A2 mRNA
CTD
PMID:23153324
NCBI chr 5:75,738,008...75,748,542
Ensembl chr 5:75,738,024...75,748,542
G
Slc34a2
solute carrier family 34 member 2
decreases expression
EXP
Mirex results in decreased expression of SLC34A2 mRNA
CTD
PMID:23153324
NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436
G
Slc38a1
solute carrier family 38, member 1
increases expression
EXP
Mirex results in increased expression of SLC38A1 mRNA
CTD
PMID:23153324
NCBI chr 7:127,733,230...127,802,541
Ensembl chr 7:127,738,226...127,802,218
G
Slc4a7
solute carrier family 4 member 7
increases expression
EXP
Mirex results in increased expression of SLC4A7 mRNA
CTD
PMID:23153324
NCBI chr15:10,585,307...10,664,780
Ensembl chr15:10,588,979...10,664,781
G
Slc5a6
solute carrier family 5 member 6
decreases expression
EXP
Mirex results in decreased expression of SLC5A6 mRNA
CTD
PMID:23153324
NCBI chr 6:25,319,187...25,331,713
Ensembl chr 6:25,320,442...25,331,712
G
Slc7a2
solute carrier family 7 member 2
decreases expression
EXP
Mirex results in decreased expression of SLC7A2 mRNA
CTD
PMID:23153324
NCBI chr16:51,417,478...51,470,784
Ensembl chr16:51,417,493...51,470,784
G
Slc7a6
solute carrier family 7 member 6
decreases expression
EXP
Mirex results in decreased expression of SLC7A6 mRNA
CTD
PMID:23153324
NCBI chr19:34,073,472...34,100,268
Ensembl chr19:34,074,286...34,100,268
G
Tat
tyrosine aminotransferase
multiple interactions
EXP
[Mirex co-treated with Corticosterone] results in increased activity of TAT protein
CTD
PMID:2893471
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Trip13
thyroid hormone receptor interactor 13
increases expression
EXP
Mirex results in increased expression of TRIP13 mRNA
CTD
PMID:23153324
NCBI chr 1:29,357,093...29,402,078
Ensembl chr 1:29,357,130...29,402,074
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all